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Hyperglycemia in liver transplantation: A frequent
event or risk factor?
La hiperglucemia en el trasplante hepático. ¿Un evento frecuente o und
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Hyperglycemia in hospitalized patients has frequently been
associated with a higher risk for infections, longer hospital
stay, and greater mortality.1,2 It is a frequent phenomenon
in posttransplantation patients, and most likely is related
to the exogenous and endogenous production of cate-
cholamines due to surgery, immunosuppression, and in some
cases, diabetes mellitus.3 Even though there are studies
on patients with kidney transplant and with liver trans-
plant (LT) showing that those presenting with perioperative
and postoperative hyperglycemia4--5 have a greater inci-
dence of acute rejection and related complications, other
groups have shown no beneﬁt from carrying out a strict
control of glycemia in the perioperative period of LT
patients.6
The study by Builes-Montan˜o et al.7 evaluates whether
hyperglycemia during the ﬁrst 48 h after LT is associated
with a greater risk for infection, rejection, or longer hospital
stay. It is a retrospective study that deﬁnes hyperglycemia
as a value above 140mg/dL and is measured in 3 differ-
ent manners (as an isolated value, as a mean value, and
as a time-weighted value). The authors concluded that
hyperglycemia is a very frequent event in LT; 94% of the
patients presented with some form of hyperglycemia dur-
ing the ﬁrst 48 post-transplantation hours and there was no
greater risk for rejection, infection, or longer hospital stay.
Unfortunately, the study has certain limitations due to its
retrospective design. Of the 316 patients that underwent
liver transplantation, more than half of them (152 patients)
were excluded because of incomplete results or due to death
within the ﬁrst 48 h. This is striking, given that in the ﬁrst
2 post-transplantation days, a glucose test is one of the
most important studies for monitoring allograft function and
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here is hypoglycemia.
Even with 3 different deﬁnitions of hyperglycemia, no sig-
iﬁcant difference was found in relation to complications.
t is also worth mentioning that both this study’s deﬁni-
ion of hyperglycemia (>140mg/dL) and the mean glycemia
f posttransplantation patients at the time of admission to
he intensive care unit (ICU) of 182 ± 55mg/dL, are ﬁgures
hat are below what other groups have regarded as hyper-
lycemia (> 200mg/dl). Park et al. conducted the largest
tudy on glycemic control in patients that underwent LT.
hey evaluated 680 patients and in the multivariate analysis
ound that hyperglycemia > 200mg/dL was a risk factor for
ostoperative surgical site infections, although they focused
xclusively on intraoperative hyperglycemia.8 Wallia et al.
lso demonstrated that a glycemia value > 200mg/dL was
risk factor for acute rejection.5 It is possible that the
alue of 140mg/dL as hyperglycemia used by Builes-Montan˜o
t al. was low for detecting differences in relation to post-
ransplantation complications.
It is important to mention that when the authors com-
ared the diabetic and nondiabetic patients, looking for
ifferences, they found none, and the diabetic patients
howed no greater risk for infection or differences in length
f hospital stay.7 Doubtlessly, the diabetic patients that were
ble to undergo LT after having gone through the evalua-
ion protocol, did not present with the chronic complications
haracteristic of diabetes mellitus, and thus the populations
ere quite comparable.
The information presented here is valuable. Neverthe-
ess, due to the limitations inherent in a retrospective and
bservational study such as this, it is difﬁcult to conﬁrm that
yperglycemia does not represent a risk for a greater num-
er of complications, as has been demonstrated in other
ypes of populations, such as patients that present with
erebrovascular accident, acute myocardial infarction, or
ardiac surgery.9,10 One would think that a prospective and
andomized study in which glycemia is strictly controlled in
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ne group of patients and not controlled in another would be
logical design, but results of such studies have also been
mbiguous. In some reports on patients that underwent kid-
ey transplantation and critically ill patients in the ICU, the
isk for hypoglycemia appeared to be greater than the bene-
ts of glycemic control, whereas in other reports speciﬁcally
n LT, intensive insulin protocol use was shown to be safe
nd effective, but no advantages were found in relation to
omplications in patients with strict glucose monitoring.6
Therefore, we can say that hyperglycemia is a frequent
henomenon in post-LT patients that apparently does not
ncrease the risk for complications; most likely these present
s a consequence of other factors, such as characteristics of
he donor, surgical aspects, the perioperative management
f anesthesia, the use of immunosuppressant drugs, and the
egree of severity of the LT patient’s health status.
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